CEA Results Explained: High Levels, Trends and Colorectal Cancer

Updated 2026-10-29

CEA, or carcinoembryonic antigen, is a tumor marker most often used to monitor colorectal cancer and some other diagnosed cancers. It is not a cancer screening test. A high result needs context, and a normal result does not rule out recurrence.

What CEA measures

CEA is a protein measured most commonly in blood. Some cancers release more of it, making repeated measurements useful as one part of follow-up. Not every cancer produces CEA, and it is not specific to colorectal cancer.

The test does not identify a mutation or show whether a targeted treatment will work. It is a monitoring signal, not a molecular treatment-selection result.

Normal range and the effect of smoking

Reference ranges depend on the laboratory and may differ for people who smoke. Some laboratories use around 2.5 ng/mL for nonsmokers and 5 ng/mL for smokers. These are examples, not universal cutoffs. Use your report’s range.

Smoking can elevate CEA. A clinician still needs to evaluate a sustained or unexplained rise rather than assume that smoking explains it.

Other reasons CEA can be elevated

Liver or digestive conditions and some inflammatory or respiratory illnesses can increase CEA. A single elevated result cannot distinguish those causes from cancer.

Check whether the result comes from the same laboratory as earlier results. The size and persistence of the change, the original cancer diagnosis and other clinical findings matter more than a flag beside one number.

Rising CEA after surgery or during treatment

A fall after treatment can support a response when CEA was elevated initially. It does not prove that all cancer has been removed. A persistent increase can prompt reassessment or imaging, but it cannot locate recurrence.

Do not wait for the next marker test if you develop concerning symptoms. A normal CEA does not make new symptoms unimportant. Your team can explain the appropriate follow-up schedule for your stage and treatment history.

Questions to ask your oncology team

• Was CEA elevated when my cancer was diagnosed?
• Is this marker reliable for following my cancer?
• Could smoking, liver disease or inflammation be contributing?
• Is the change large enough to warrant a repeat test or imaging?
• What would we do if the next result rises again?

CEA versus ctDNA and genomic testing

CEA measures a protein. ctDNA testing looks for tumor DNA in blood, while tumor genomic profiling identifies alterations that may inform treatment. These results are not interchangeable. See MRD test results and KRAS mutation results.

Preparing for a personal review

Keep the complete report, not just a screenshot of the flagged line. Include previous results, scan reports and a brief treatment timeline if you decide to arrange a review. These details help distinguish what the test actually shows from questions it cannot answer.

MITOTICS® provides independent scientific interpretation and decision support. Kim Lockheimer, PhD, DFM, is a clinical scientist, not a physician. Diagnosis, prescribing and treatment decisions remain with your treating team. Do not change treatment based on this guide.

Frequently asked questions

References and further reading

1. CEA Test
2. CEA blood test

A free 15-minute call is a brief conversation about your needs and whether personal review is appropriate. No records or payment needed.